Clinical observation on the therapeutic effect of Tongxinluo capsule on depression in patients with coronary heart disease

曹振东,毛家亮,鲍正宇,吴胜斌
DOI: https://doi.org/10.3969/j.issn.1671-6450.2006.04.004
2006-01-01
Abstract:Objective To investigate the therapeutic effect of Tongxinluo capsule on depression in patients with coronary heart disease (CHD).Methods 80 Patients with CHD and depressive disorders were randomly divided into two groups,the 40 patients in observation group were treated with Tongxinluo capsule and the other 40 patients in control group were treated with sertraline, with a treatment course of 8 weeks for both groups. The therapeutic effect was evaluated by HAMD periodically.Results The total effective rate in observation group was 87.5%,which was 90.0% in control group,there was no significant difference in scores of HAMD between the two groups after one,two,four,eight weeks (P>0.05).In the 4 paramenters of HAMD,the therapeutic effect of sleep disorders,anxiety and depression emotions,somatic syndromes were approximately the same,while the therapeutic effect of affective disorders in observation group was worse tham that in control group.Conclusion Tongxinluo capsule is effective in treating depressive disorders in patients with CHD.
What problem does this paper attempt to address?